February 3, 2023

Health Mettler Institute

Healthy LifeStyle & Education

$20M gift to boost innovation in health and technology

A $20 million present from Andrew H. ’71 and Ann R. Tisch will foster engagement and collaboration in between Cornell Tech and Weill Cornell Medication, catalyzing new discoveries at the intersection of wellness and know-how – ranging from precision, genomics-primarily based medicine to the use of synthetic intelligence and equipment discovering to strengthen medical care.

The Tisch School Aid system will be managed in between Weill Cornell Medication and Cornell Tech. The reward will help the recruitment of an inaugural chair of the new Division of Units and Computational Biomedicine at Weill Cornell Medication, and endow a professorship to be held by the chair it will also endow one senior- and just one junior-degree professorship at Cornell Tech in the space of health and fitness technology.

Andrew H. ’71 and Ann R. Tisch

“This wonderful new assistance from Andrew and Ann Tisch will fuel the pathbreaking collaboration and innovation of our school at the vital interface of medicine and technology,” explained President Martha E. Pollack. “I am so grateful for their investment decision in this thrilling area of exploration, where by college exploration is poised for translation into substantial human effects.”

Taken collectively, the new positions will strengthen the inbound links among both campuses’ foundational science, computational science and medical-care applications, and generate pioneering discoveries that will immediately have an effect on clients and improve their treatment.

“Next-technology technology has the opportunity to renovate the health care landscape, providing critical new scientific insights that will improve and personalize the care we give our patients,” reported Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medication. “Andrew and Ann Tisch’s generous reward, for which we are profoundly appreciative, will help us recognize this likely.”

The new Office of Programs and Computational Biomedicine is a result of Weill Cornell Medicine’s efforts to enhance the composition, business and scope of its scientifically oriented tutorial departments, institutes and centers. The department will convey collectively experience in regions ranging from devices biology and biomedical purposes of artificial intelligence and device learning, to deep molecular phenotyping technologies. Departmental faculty will harness the ability of reducing-edge technologies and AI and computational science methods to strengthen human overall health, when launching a critical hub for scientific collaboration across Cornell’s campuses.

The office chair, who will maintain the Andrew H. and Ann R. Tisch Professorship of Units and Computational Biomedicine, will collaborate with faculty from the Englander Institute for Precision Drugs at Weill Cornell Drugs, Cornell Tech and Weill Cornell Medicine-Qatar to inform the department’s work with a vary of experience in pc science, biomedical engineering, functional and evolutionary genomics, nanotechnology, the whole spectrum of omics technologies, and facility with model and non-model organisms. The chair will also foster new systems with sector and in entrepreneurship with the assist of Weill Cornell Drugs Business Innovation.

“The Tisches have always played a leadership role in encouraging our campus excel,” mentioned Greg Morrisett, the Jack and Rilla Neafsey Dean and Vice Provost of Cornell Tech. “Their reward will deliver crucial resources to permit us to collaborate additional intently with Weill Cornell Medication and other health and fitness care gamers to progress the effects of digital wellness technologies.”

The investments in Cornell Tech college will speedy-track discovery and collaboration with business associates, and generate impact via the campus’s domain-targeted hubs in health and fitness tech, urban tech and connective media. The new school positions will also further more improve relationships between Cornell Tech and the Jacobs Technion-Cornell Institute at Cornell Tech, Weill Cornell Medication and the Ithaca campus.

“Ann and I are fired up to support the foundational and used study and schooling, and amazing individual care, that have created Cornell Tech and Weill Cornell Drugs this kind of leaders in their fields,” claimed Andrew Tisch. “Accelerating their partnership and collaboration will lead to the kind of medical and technological breakthroughs that have the potential to remodel lives and assist to make improvements to the environment.”

Andrew Tisch is co-chairman of the board and chairman of the government committee of Loews Corp., as properly as chairman of the Dean’s Leadership Council of the Cornell S.C. Johnson University of Company, chairman of the Exterior Relations Committee of the Weill Cornell Medication Board of Fellows, vice chair of Weill Cornell Medicine’s We are Transforming Drugs marketing campaign and a member of the Cornell Tech Council. Ann Tisch, a former national correspondent for NBC Information, is the founder and president of Student Management Community, an business that operates the Young Women’s Leadership Colleges, a community of all-girls community faculties, and CollegeBound Initiative, a co-ed university accessibility system.

For decades, the Tisch household have been among the university’s most generous supporters. In 2002, Andrew Tisch and brother James S. Tisch ’75 set up the Andrew H. and James S. Tisch Distinguished College Professorship. A reward from Andrew and Ann in 2008 recognized the Tisch University Professorships, one particular of Cornell’s greatest faculty honors. A present in 2010 supported Weill Cornell Medicine’s Discoveries that Make a Difference marketing campaign, with a particular focus on neuroscience and cardiology. And a gift in 2016 produced an endowed professorship at the Jacobs Institute.